| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/30/1993 | CN1073677A 20-methyl-substituted vitamin D-derivatives |
| 06/29/1993 | US5223513 Quinoline derivatives, their production and use |
| 06/29/1993 | US5223498 Phenylamidine and phenylguanidine derivatives and their use as antidiabetic agents |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | CA1319607C Antithrombotic pharmaceutical preparation and process for preparing same |
| 06/27/1993 | CA2086277A1 Thiazolidine compounds, their preparation and their therapeutic uses |
| 06/25/1993 | CA2086160A1 Use of n-substituted n-phenylsulfonylurea in the treatment of high blood pressure in insulion-resistant subjects |
| 06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 06/24/1993 | WO1993012122A1 Novel phosphono-succinic acid derivatives, process for producing them and medicaments containing these compounds |
| 06/24/1993 | WO1993012118A1 Novel substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/24/1993 | WO1993012089A1 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| 06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
| 06/24/1993 | WO1993012081A1 20-methyl-substituted vitamin d derivates |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011786A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 06/24/1993 | WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/24/1993 | WO1993006811A3 Vanadium compositions |
| 06/24/1993 | DE4141928A1 Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New phosphonobernsteinsaeurederivate, process for their production and pharmaceutical compositions containing them |
| 06/24/1993 | CA2125867A1 Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds |
| 06/23/1993 | EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation |
| 06/23/1993 | EP0547545A1 Pharmaceutical composition for the inhibition of bone resorption |
| 06/23/1993 | EP0547422A2 Stable powdery vitamin and/or carotinoid preparations and process for their production |
| 06/23/1993 | EP0547334A1 Combination of calcium antagonists with cholinesterase inhibitors for the treatment of senile demention |
| 06/23/1993 | EP0547234A1 Remedy for osteoporosis |
| 06/23/1993 | EP0547151A1 TREATMENT PROCESS FOR PROMOTING WEIGHT LOSS EMPLOYING A SUBSTITUTED $g(D)5-ANDROSTENE |
| 06/23/1993 | EP0547099A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa. |
| 06/23/1993 | CN1073437A Pharmaceutical compounds |
| 06/23/1993 | CN1073428A Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 06/23/1993 | CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use |
| 06/22/1993 | US5221668 Partially digested protein and L-arginine |
| 06/22/1993 | CA1319363C 3-demethyl-4-fluoromevalonic acid derivatives, a process for the preparation thereof, pharmaceutical products based on these compounds, the use thereof, and intermediates |
| 06/22/1993 | CA1319362C 4-substituted androstendione derivatives and process for their preparation |
| 06/21/1993 | CA2085830A1 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors |
| 06/21/1993 | CA2085782A1 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 06/20/1993 | CA2085687A1 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| 06/17/1993 | DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives |
| 06/17/1993 | CA2085421A1 Pharmaceutical composition for the inhibition of bone resorption |
| 06/17/1993 | CA2085399A1 Method for inhibiting nitric oxide formation |
| 06/16/1993 | EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound |
| 06/16/1993 | EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/16/1993 | EP0546548A1 Guanidinyl alkyl-1,1-bis phosphonic acid derivatives, process for their preparation and their use |
| 06/16/1993 | EP0546123A1 Alpha-substituted tryptophane dipeptoid derivatives |
| 06/16/1993 | EP0546108A1 Pro-drugs for cck antagonists |
| 06/16/1993 | EP0546007A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients. |
| 06/16/1993 | EP0545972A1 Therapeutically active mixture of glutathion and anthocyan compounds. |
| 06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
| 06/16/1993 | EP0112332B1 Vitamin d glycosides |
| 06/16/1993 | CN1021223C Process for 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols |
| 06/15/1993 | US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors |
| 06/15/1993 | US5219879 Heterocyclic steroid compounds |
| 06/15/1993 | US5219864 Thienopyridine derivatives |
| 06/15/1993 | US5219859 Indole derivatives, preparation processes and medicinal products containing them |
| 06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
| 06/15/1993 | CA1319148C Thyronine analogous compounds |
| 06/15/1993 | CA1319145C Substituted 3-piperidinamines or 3-azepinamines, the preparation thereof and their applications in therapy |
| 06/14/1993 | CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/13/1993 | CA2085215A1 Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level |
| 06/10/1993 | WO1993011126A1 1'-amino-2-[(benzothiazolyl)methyl]spiro [isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 06/10/1993 | WO1993011106A1 Indole derivatives |
| 06/10/1993 | WO1993011101A1 Derivatives of arylsulphoacids having hypoglycemic activity |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010775A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | WO1993003714A3 Method for treatment of metabolic disorders |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/10/1993 | CA2123677A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | CA2122916A1 1-amino-2-[(benzothiazolyl)methyl] spiro [isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)- tetrones and analogs thereof useful as aldose reductase inhibitors |
| 06/09/1993 | EP0545845A1 Imidazole compounds, their preparation and use as calcium channel blockers |
| 06/09/1993 | EP0545805A1 Use of D-fenfluramine and fenfluramine derivatives in the treatment of hypertension in insulin-resistant patients |
| 06/09/1993 | EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 06/09/1993 | EP0545198A2 Peptides with insulin like activity |
| 06/09/1993 | EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying |
| 06/09/1993 | EP0415941B1 Nutrient composition and method for the preparation thereof |
| 06/09/1993 | CN1072929A Para-dinitrogen naphthalene derivative its preparation process and its medical use |
| 06/08/1993 | US5217994 Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| 06/08/1993 | US5217992 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 06/07/1993 | CA2084641A1 Use of d-fenfluramine and fenfluramin derivatives for treating high-blood pressure in insulin-resistant subjects |
| 06/04/1993 | CA2084233A1 Imidazole compounds, their preparation and use |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | EP0544466A1 Tri-arginine insulins |
| 06/02/1993 | EP0543891A1 Diphenylurea derivatives |
| 06/02/1993 | EP0543884A1 Benzanilide derivatives and their use as anti-atherosclerotic agents |
| 06/02/1993 | EP0543865A1 Benzamide derivatives |
| 06/02/1993 | EP0543855A1 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis |
| 06/02/1993 | CN1072723A Tri-arginine insulins. |
| 06/02/1993 | CN1072679A 吲哚衍生物 Indole derivatives |
| 06/02/1993 | CN1072601A Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 06/01/1993 | US5215990 Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents |
| 06/01/1993 | CA1318674C Antihypercholesterolemic .beta.-lactones |
| 05/27/1993 | WO1993010254A1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 05/27/1993 | WO1993010146A1 Amylin agonist peptides and uses therefor |
| 05/27/1993 | WO1993009820A1 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | WO1993009777A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | WO1993009776A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 05/27/1993 | WO1993009769A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124086A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | CA2123782A1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |